Related by context. All words. (Click for frequent words.) 69 INSPIRE Trial Phase III 68 Bayer HealthCare Onyx Pharmaceuticals 68 solid tumors ZYBRESTAT 67 Empatic ™ 67 includes TOLAMBA TM 66 CYT# potent vascular disrupting 66 recombinant PSMA vaccine 66 Hedgehog Pathway Inhibitor 66 relapsed MM 66 LymphoStat B belimumab 66 verdict elicited gasps 66 sapacitabine CYC# 65 R# #mg BID 65 EOquin TM phase 65 ThermoDox ® clinical 65 novel VDA molecule 65 REVIVE TA 65 CHAMPION PCI 65 Phase 1b clinical trials 65 BRIM3 65 initiate multicenter 65 phase Ib 65 Deforolimus 65 Severe hypersensitivity reactions 65 ragweed allergy immunotherapeutic 65 evaluating mipomersen 64 pralatrexate injection folate analogue 64 Telik logo TELINTRA 64 pharmacogenomic translational research 64 Teplizumab 64 multicenter Phase III 64 Syncria albiglutide 64 candidates Azedra TM 64 Crofelemer budesonide foam 64 unique alkylating agent 64 recurrent metastatic ovarian cancer 64 compound INCB# 64 R sorafenib tablets 64 YOUR LOCAL ANIMAL SHELTER 64 MAGE A3 ASCI 64 rumpled dresser 64 pivotal bioequivalence 64 Completes Patient Enrollment 64 Hsp# Inhibitor 64 blinded randomized placebo controlled 64 ADVANCE ILLUMINATE 64 APEX PD 64 AAG geldanamycin analog 64 Charles Dullin School 64 Budesonide foam crofelemer 64 MKC# MT 63 systemic Phase 1b 63 refractory chronic lymphocytic 63 Combination REOLYSIN R 63 Initiates Enrollment 63 Prostate AdenoCarcinoma Treatment 63 Zolpimist ™ 63 acyclovir Lauriad R 63 damage cirrhosis liver 63 malignant mesothelioma Alfacell 63 multicenter Phase II 63 INTEGRILIN R eptifibatide Injection 63 treatment naive genotype 63 Telik Announces 63 kidney urologic 63 SinuNase ™ 63 Aldean Shelton 63 albiglutide 63 ENABLE Phase 2 63 By JENNIFER LEARN 63 tramiprosate Alzhemed TM 63 Glufosfamide 63 Pharmacokinetic parameters 63 CEL SCI Phase III 63 Evidence Therapeutic study 63 commercialize CorMedix drug 63 Omacetaxine 63 EQUIP OB 63 XL# anticancer compounds 63 EXPLORE Xa 63 Phase Ib clinical 63 number NCT# ClinicalTrials.gov 63 Taliban bullets whizzed 63 dimebon latrepirdine 63 EDEMA3 63 PSMA ADC 63 RSD# oral 63 RECORD1 63 HCV SPRINT 63 EMPOWER ™ 63 successfully commercialize Iluvien 63 non cirrhotic portal 63 Genz # 63 budesonide foam 63 non nucleoside HCV 62 anti VEGF aptamer 62 Perifosine KRX 62 bevirimat Study 62 CONQUER OB 62 J Immunol 62 Evoltra ® 62 BRIM2 62 Gentamicin Surgical Implant 62 FOLOTYN ® 62 Oral NKTR 62 novel emulsion formulation 62 DermaVir Patch 62 Phase Ib II 62 PMX # heptagonist 62 Forages Cabo Inc. 62 MKC# MKC# PP 62 Targretin capsules 62 Shortened telomeres 62 phase IIb trial 62 GATTEX ™ 62 Auxilium anticipates 62 include ColorectAlert TM 62 agonistic human 62 oral picoplatin 62 alvespimycin 62 By Gene Haschak 62 YONDELIS 62 Prednisone Against Refractory 62 demonstrated antitumor activity 62 lintuzumab SGN 62 humanized therapeutic 62 Safinamide 62 FDA Approves Novel 62 NSABP C 62 Phase Ib IIa 62 Phase III metastatic melanoma 62 AirBoss Announces 62 SPRYCEL ® 62 dirucotide MBP# 62 PLX STROKE targeting 62 phase IIb clinical 62 interferon gamma 1b 62 multicenter Phase 62 vaccine GMK 62 ToGA 62 Aeolus Pharmaceuticals Announces 62 multicenter placebo controlled 62 AMWO 62 Oral Calcitonin 62 ALS #-# 62 Saturn Uranus Neptune 62 neuropathic pain spasticity 62 Motesanib 62 Second Pivotal Phase 62 Baqoubah north 62 generation URAT1 inhibitor 62 ANCHOR trial 62 ORAL Solo 62 FOLFOX6 chemotherapy regimen 62 AVOREN 62 evaluating Actimmune 62 receptor tyrosine kinase inhibitor 62 PI3K/Akt pathway inhibitor 62 oncolytic virus therapies 62 confirmatory pivotal 62 riociguat 61 Research www. elsevier.com 61 Phase #b/#a clinical 61 fusion enhancers 61 novel orally inhaled 61 IMPDH inhibitor 61 confirmatory clinical 61 TMC# C# 61 Cariprazine 61 HGS ETR1 mapatumumab 61 SUTENT ® 61 somatostatin analog 61 Exelixis compounds 61 ATRA IV 61 microsurgical disciplines 61 intravenous RSD# 61 EDEMA4 61 cosmetic cosmeceutical products 61 placebo controlled multicenter 61 PrevOnco 61 TM pralatrexate injection 61 MEND CABG 61 PrevOnco ™ 61 TRANSDUR ® 61 bepotastine besilate nasal spray 61 certain protein tyrosine 61 European Sepsis Trial 61 Xanafide 61 forodesine 61 var arrContent = 61 serine protease inhibitor CU# 61 Phase 2a Trial 61 brand ciclesonide HFA 61 adecatumumab MT# 61 COSIRA trial 61 Phase IIIb clinical 61 Phase 2b Clinical Trial 61 Randomized Phase II 61 Sapacitabine 61 Annamycin 61 intravesical infusion therapy 61 initiated Phase Ib 61 ZYBRESTAT fosbretabulin 61 Stab stab 61 ALN VSP Phase 61 anaphylactic reactions bronchospasm 61 DEB# 61 Testosterone MDTS ® 61 Trastuzumab DM1 61 Non Alcoholic Steatohepatitis 61 BCG refractory carcinoma 61 evaluating picoplatin 61 evaluating satraplatin 61 NATIONAL ECONOMIC COUNCIL DIRECTOR 61 undergoing elective percutaneous 61 myocardial infarction ventricular fibrillation 61 IMiDs 61 STRIDE PD 61 VEGFR2 inhibitor 61 SUCCEED trial 61 AIR CF1 61 DIFICID ™ 61 treatment naïve genotype 61 Medullary Thyroid Cancer 61 gastrin analogue TT 61 evaluating tivozanib 61 sitaxsentan 61 GVAX ® 61 de novo kidney transplant 61 midstage clinical 61 LymphoStat B TM 61 Phase 1b trial 61 Phase IIb III 61 Lifeguard Collin Cobia 61 balloon hem minidresses 61 CIMZIA ™ 61 CYP#A# CYP#D# 61 HCV NS5B polymerase 61 cytokine refractory 61 GERD migraine headaches 61 phase IIb study 61 OvaRex ® MAb 61 ® bortezomib 61 elderly myelodysplastic syndromes 61 NS5B polymerase 61 CAMMS# 61 Zemplar Capsules 61 elotuzumab 61 Array BioPharma Reports 61 PRECISE Trial 61 cisplatin gemcitabine 61 Namenda Memantine HCl 61 MERLIN TIMI 61 CRMD# 61 black Landcruisers 61 PROVENGE ® 61 Temsirolimus 61 includes investigational compounds 61 deCODE AF TM 61 Ribavirin causes 61 Phase 2a trial 60 angiotensin analog 60 R#/MEM # 60 Zenvia ™ 60 including eniluracil ADH 60 LungAlert TM 60 PEGylated docetaxel 60 alpha antagonist 60 www.pranabio.com 60 HCD# [002] 60 RTP #i 60 ExTRACT TIMI 60 avanafil PDE5 inhibitor 60 Topline Results 60 opioid naive 60 Phase #/#a trial 60 REMINYL ® 60 var arrMeta = 60 GRNOPC1 contains 60 5 HT2A inverse 60 registrational trial 60 HMG CoA reductase inhibitors 60 REVIVE Diabetes 60 Submits Response 60 Ceflatonin R 60 sorafenib tablets 60 miconazole Lauriad ® 60 #:#-#,# CrossRef Medline [001] 60 TRANSDUR ™ 60 Medidur TM FA 60 PERSEUS clinical program 60 dose escalation Phase 60 Other ImmunoGen collaborative 60 CYP#A# isoenzyme 60 Phase III ADT 60 MEND CABG II 60 Pruvel TM 60 Clinical Trials Update 60 Chevrolet Malibu #.#L I4 60 Invasive pneumococcal disease 60 OMNARIS Nasal Spray 60 Val HeFT 60 SPEAR Study 60 GetGoal Phase III 60 Thalomid ® 60 leading oral taxane 60 XL# XL# XL# XL# 60 Kidney Int 60 Mg Uk 60 CCR5 mAb 60 Cancer Incidence Mortality 60 GATTEX ® 60 trastuzumab emtansine T DM1 60 OvaRex R 60 clinical trials Archexin 60 deforolimus 60 evaluating bafetinib 60 Planetwide Media My 60 DIRECT Trial 60 azilsartan medoxomil 60 GATTEX TM 60 CTAP# Capsules 60 SinuNase TM 60 oral deforolimus 60 CTA# Injection 60 AKT inhibitor 60 Renal Cell Carcinoma RCC 60 eprotirome 60 Prodarsan R 60 tramiprosate ALZHEMED TM 60 phase Ib clinical 60 Phase 1a clinical 60 Exherin TM 60 registrational Phase 60 next generation URAT1 60 MVA MUC1 IL2 60 nucleotide analog 60 approved incretin mimetic 60 accompanying electrolyte abnormalities 60 var arrUrl = 60 TOCOSOL Camptothecin 60 Hormone Refractory Prostate Cancer 60 Amigal TM 60 phase 2a 60 rheumatoid arthritis thrombocytopenia 60 By CASSIE HEWLINGS 60 lymphoma multiple myeloma 60 TNFerade ™ 60 sarcoma melanoma 60 TACI Ig 60 virus HCV protease inhibitor 60 delivers fluocinolone acetonide FA 60 J Antimicrob Chemother 60 Actimmune ® 60 include Ischemic Paraplegia 60 galiximab 60 oral proteasome inhibitor 60 Solazed TM 60 non nucleoside inhibitor 60 novel antimitotic agent 60 PNP inhibitor 60 BR.# 60 class mGluR5 inhibitor 60 DASISION 60 myelofibrosis polycythemia vera 60 First Patient Enrolled 60 Bucindolol 60 Daclizumab 60 ENESTnd 60 basal bolus regimen 60 initiate Phase IIb 60 Prada Gucci Fendi 60 oral ridaforolimus 60 morphometric vertebral fractures 60 NO# [002] 60 Epratuzumab 60 placebo controlled Phase 60 Quinamed R 60 rheumatoid arthritis inflammatory bowel 60 progressive metastatic prostate 60 cardio renal 60 pharmacokinetic PK study 60 Tesmilifene 60 Custirsen 60 Testosterone MDTS R 60 VIVITROL ® 60 Demonstrates Positive 60 company website www.novavax.com 60 depressive episodes associated 60 please visit http:/www.sunesis.com 60 Tanespimycin 60 Aflibercept 60 AVN# Phase 60 Degarelix 60 gastro intestinal inflammation 60 RE LY 60 acetonide FA 60 Acute Decompensated Heart Failure 60 Cerebral Amyloid Angiopathy 60 Phase IIa trials 60 ONGLYZA saxagliptin 60 multicenter multinational 60 Multicenter Phase 60 Phase 2b clinical trials 60 novel oral anticoagulant 60 StemEx 60 Warhol Jasper Johns 60 products MKC# PP 60 gastrointestinal disorders ATI 60 ABSORB clinical 60 OncoVex 60 Hepatocellular Carcinoma HCC 60 signal detection CTSD 60 orally administered inhibitor 60 Multiple Ascending Dose 60 candidate CRLX# 60 stage IIIb IV 60 Successfully Completes Phase 60 MT#/MEDI-# 60 multicenter randomized placebo controlled 60 Commences Phase 60 albiglutide currently 59 gastrointestinal stromal 59 Personalized Immunotherapy 59 SIMCOR ® 59 dyslipidemia hypertension diabetes 59 granted Ortec 59 NATRECOR ® 59 RhuDex TM 59 multinational multicenter randomized 59 Woodlands Entrance 59 Initiates Phase II 59 web site http:/www.gtc-bio.com 59 brivanib 59 Synta Announces 59 randomized controlled multicenter 59 Orosi Mill project 59 Vitrasert R 59 Phase IIA 59 HuLuc# 59 apricitabine ATC 59 LUX Lung 59 dose escalation clinical 59 Vasogen Announces 59 PROSTVAC ® 59 Hypertensive adverse reactions 59 TELINTRA R 59 XL# SAR# 59 product platforms AZX# 59 cancer neuroendocrine tumor 59 bazedoxifene conjugated estrogens 59 Tumor Response 59 rALLy clinical trial 59 CYP#A# substrate 59 MKC# 59 novel therapeutic antibodies 59 rash pruritus nausea 59 BCIRG 59 Phase III LibiGel 59 dependent kinase inhibitor 59 PRIMO CABG2 59 AEG# 59 AFREZZA TM 59 lumiliximab 59 novel synthetic PEGylated 59 colorectal ovarian endometrial 59 Amrubicin 59 relapsed Acute Myeloid 59 Phase Ib study 59 Teriflunomide 59 Initiates Phase III 59 AcryMed technologies 59 Demonstrates Sustained 59 Toyota Corolla #.#L I4 59 Phase #/#a 59 IMA# 59 deCODE ProstateCancer TM 59 RELOVAIR ™ 59 PF # [002] 59 AN# topical anti 59 TransVax TM 59 Presents Preclinical 59 PARGLUVA 59 cladribine Cladribine Tablets 59 Phase IIIb 59 Acute myelogenous leukemia 59 Severe Sepsis 59 evaluating satraplatin plus 59 Presents Positive 59 Gabapentin GR TM 59 LUMINATE 59 Initiate Phase 59 EDEMA3 trial 59 Phase III multicenter 59 Recurrent Glioblastoma 59 trastuzumab Herceptin R 59 SYMMETRY SM trial 59 PORxin TM platforms 59 personalized cellular immunotherapy 59 RAS MAPK pathway 59 Initiate Phase III 59 website www.novavax.com 59 Xeloda ® 59 Fludara ® 59 pentadentate logo R 59 Canvaxin TM 59 targeting miR 59 lomitapide 59 develop HBV reactivation 59 ularitide 59 DU #b 59 LibiGel Phase III 59 DCVax R 59 evaluating T DM1 59 Saxagliptin 59 Alzheimer disease cognitive impairment 59 HepeX B TM 59 MGd 59 phase IIIb 59 HGS# 59 Rigel R# 59 metaglidasen 59 Randomized Phase 59 Nuvelo Announces 59 EXECUTIVE SUMMARY II 59 Chennai Kochi Thiruvananthapuram 59 Phase IIb clinical trials 59 systemic anaplastic large 59 DDi Corp. Announces 59 theatrical brio 59 Decompensated Heart Failure 59 nsack@californian.com 59 synthetic retinoid 59 CVx ChannelVision Expo 59 PRESEPT 59 Genentech Wyeth Pharmaceuticals 59 Treatment Shows Promise 59 Maximum Tolerated Dose MTD 59 mark eOn 59 R lenalidomide 59 C1 INH deficiency 59 Cardiotoxicity 59 CLARITY study 59 TO AVOID PREGNANCY WHILE 59 AcryMed Incorporated 59 ABSORB trial 59 Pirfenidone 59 dose escalation phase 59 vapreotide acetate 59 IIb clinical trial 59 randomized Phase 2b 59 MIVI TRUST 59 Phase IIb randomized 59 placebo controlled clinical 59 CRLX# 59 Tarceva TM 59 By TED HARBIN 59 Prospective Randomized 59 interferon alpha IFN 59 peptidic compound 59 Farfan Juan Pablo 59 Vectibix panitumumab 59 evaluating intravenous picoplatin 59 Phase 2a IBS 59 Allovectin 7 59 Dose escalation 59 DNA methyltransferase inhibitors 59 HGS ETR1 59 SNT MC# 59 Pharmos pipeline 59 tolevamer 59 Phase Ib clinical trials 59 Silodosin 59 Clot Busting 59 oral rivaroxaban 59 Begins Dosing 59 CATIE AD 59 drug figitumumab 59 BLOOM Behavioral modification 59 ELADUR ™ 59 Iloperidone 59 plasma kallikrein inhibitor 59 EMPHASIS HF trial 59 See CLINICAL PHARMACOLOGY 59 Mg Usa 59 induced macular edema 59 LAB CGRP 59 randomized controlled Phase 59 NSABP B 59 delta opioid receptor 59 FUSILEV enhances 59 CCR5 receptor antagonist 59 RANK Ligand inhibitor 59 telomerase therapeutic 59 AIMM trial 59 regorafenib 59 ongoing Phase IIIb 59 DIRECTORS OF ROCKGATE CAPITAL 59 BioNumerik 59 metastatic colorectal carcinoma 59 Octreolin 59 beta 1a 59 ADVANCE PD 59 Harpo Studios produces 59 drug pipeline TAFA# 59 paclitaxel poliglumex 59 HCV RESPOND 2 59 Entereg TM 59 ® decitabine 59 alpha folate receptor 59 TASKi2 59 Submits NDA 59 Achillion anticipates 59 CALGB 59 recurrent glioma 59 PROSTVAC VF 59 NVA# 59 3 registrational trial 59 related CMV Retinitis 59 pyrimidine nucleoside analog 59 Tasigna prolongs 59 Xelox 59 TKB# 59 ovarian esophageal 59 Allovectin 7 ® 59 PEGylated interferon beta 1a 59 MCSP respectively 59 velafermin 59 UPLYSO 59 vitamin B# folic acid 59 Phase 2b Trial 59 oral methylnaltrexone 59 VICTOR E3 59 JAK2 Inhibitor 59 4SC AG ISIN DE# 59 Phase III Pivotal 59 APTIVUS ritonavir 58 THAT ARE DIFFICULT TO 58 R Bortezomib 58 controlled multicenter Phase 58 Ophena TM 58 Endotoxin Activity Assay 58 Stern Dr. Khristine 58 OYO Geospace Reports 58 Ozarelix 58 phase IIa 58 OPT CHF 58 endothelin antagonists 58 lead Aganocide compound 58 Brentuximab Vedotin SGN 58 phase IIa clinical 58 followers Patricia Krenwinkle 58 Febuxostat 58 Forodesine HCl 58 TMC# [002] 58 candidate XP# 58 biologic antibody 58 Matrix Phase 2b 58 bapineuzumab AAB 58 Combivir Kivexa 58 osteolytic bone disease 58 www.BMRN.com 58 PRIMO CABG 58 Idiopathic pulmonary fibrosis 58 fluvastatin 58 CDK cyclin dependent 58 lenalidomide Revlimid R 58 cranium fragment 58 carcinoma mCRC 58 maximally tolerated dose 58 pharmacodynamic profiles 58 OMAPRO ™ 58 Selective Electrochemical Tumor Ablation 58 Cynosure anticipates 58 FASEB J. 58 humanized interleukin 6 58 APTIVUS 58 Strangers kissed 58 didanosine associated 58 ENMD # 58 Darinaparsin 58 EGS# 58 recurrent malignant glioma 58 oral prodrug 58 lintuzumab 58 Rilonacept 58 Pafuramidine 58 Folfox 58 specific CCR9 antagonist 58 Phase 2a clinical 58 TEMSO 58 recurrent NSCLC 58 Diamyd r 58 By FRAN SYPEK 58 Nephrol Dial Transplant 58 Granted Orphan Drug 58 here http:/blogs.nashuatelegraph.com/webnotes/#Culminating 58 relapsing remitting MS RRMS 58 refractory AML 58 Thawed permafrost releases 58 RoACTEMRA 58 investigational oral therapy 58 Myocet 58 nonhematologic adverse reactions 58 prospective multicentre 58 Pivotal Phase 58 membranous nephritis 58 rALLy 58 essential thrombocythemia ET 58 PANVAC VF 58 GOUT 58 CG# oncolytic virus 58 BioSante LibiGel Phase III 58 resistant hormone refractory 58 Dose Limiting Toxicity DLT 58 EMPOWER Study 58 CIMZIA R 58 HuMax EGFr 58 chronic myeloid 58 Tibotec Therapeutics division 58 RESTORE CLI trial 58 Vicor Technologies Announces 58 Submits Biologics License Application 58 dextromethorphan quinidine 58 ospemifene 58 Dacogen injection 58 Vicriviroc 58 GSK# [001] 58 services visit http:/www.bulltrade.com/pastResultInspirational Leadership 58 TRIOLEX HE# APOPTONE HE# 58 TRIOLEX ™ 58 Shows Promise Against 58 Buick Lucerne #.#L V6 58 Hematide ™ 58 nilotinib Tasigna ® 58 Initiates Clinical Trial 58 Airvana anticipates 58 CIMZIA TM certolizumab pegol 58 Achieves Primary Endpoint 58 registrational 58 imetelstat GRN#L 58 reddish brown muck 58 Trofex 58 receiving XGEVA 58 pexelizumab trials 58 prolific Slave Craton 58 Excellarate TM 58 Paramount Classics Insurge Pictures 58 Picoplatin Efficacy After 58 Erythropoietic therapies may 58 Projected completion 58 Femring ® 58 APEX AMI trial 58 cMET 58 PERSEUS 58 Diamyd Medical Diamyd 58 alfa 2a 58 ancrod 58 Anthracycline 58 Obes Res 58 Angiox ® 58 CINQUIL 58 inflammatory autoimmune diseases 58 via intradermal injections 58 Trabectedin 58 landmark ATHENA 58 mitoxantrone plus 58 Xcytrin R 58 HGS ETR2 58 pediatric malignancies 58 Vertex hepatitis C 58 Hedgehog Pathway 58 NMT Medical Announces 58 hoFH 58 hyperphenylalaninemia HPA due 58 cicletanine 58 Bezielle 58 HORIZONS AMI trial 58 aplindore 58 RRMS patients 58 barbiturates benzodiazepines 58 Solazed 58 Shows Efficacy 58 oral Janus kinase 58 Pagoclone 58 Kiki Von Glinow 58 SPRIX ® 58 small molecule thrombopoietin 58 arsenic trioxide injection 58 PRESEPT study 58 alpha 2A adrenergic 58 paclitaxel Taxol ® 58 ISTODAX 58 GSK# [002] 58 rALLy trial 58 neratinib 58 EchoCRT 58 Ivernia considers 58 Relapsed Multiple Myeloma 58 eritoran 58 NEBIDO VANTAS SUPPRELIN LA 58 AIR2 Trial 58 trastuzumab DM1 58 NELTY 58 hGH CTP Phase 58 selective androgen receptor modulators 58 SYMMETRY trial 58 low dose cytarabine 58 tolerability pharmacokinetics 58 Commonly prescribed 58 Acute Intermittent Porphyria 58 Lymphocytic 58 TranSwitch indebtedness 58 Truvada tablets 58 Traumatic Spinal Cord Injury 58 website www.nyandcompany.com 58 Dasatinib 58 By Bill Esbrook 58 2 inhibitor CYT# 58 histone deacetylase HDAC inhibitor 58 cathepsin K inhibitor 58 Hepatotoxicity 58 comparing XIENCE V 58 Phase IIB 58 dasatinib Sprycel ® 58 Acute Exacerbations 58 inflammatory PDE 58 small molecule Hedgehog 58 hepatitis C HCV 58 Predictive medicine 58 refractory metastatic 58 nucleoside analog 58 double blinded placebo 58 foreclosures Sharga 58 retinal vein occlusion induced 58 ENGINEERING.com Incorporated Announces 58 Infusion Reactions Severe 58 refractory cutaneous T 58 DAPT Study 58 Bosutinib 58 Efficacy Results 58 DP VPA 58 placebo controlled randomized 58 Proellex TM 58 Arch Neurol 58 renal flares 58 receiving INTRON 58 Left Ventricular Dysfunction 58 Katherine Heigl Mariska Hargitay 58 randomized multicenter Phase III 58 Stage IIB 58 Callisto initiated 58 FDA APPROVES 58 Nasdaq PGNX today 58 Randomized Double blind 58 ALSYMPCA 58 comparing alemtuzumab 58 Oral Fingolimod 58 huC# DM4 58 Desvenlafaxine Succinate 58 PROACT Phase 2 58 oral dual endothelin 58 Meets Primary Endpoint 58 PROMACTA CARES 58 Proc Am Soc 58 Phase III confirmatory 58 urocortin 2 58 PC DAC Exendin 58 triggers apoptosis programmed 58 NFM celebrated 58 BENICAR HCT 58 Prodarsan ® 58 mg/m2 cohort 58 chronic myocardial ischemia 58 CLIRS trial 58 Prolongs Survival 58 opioid induced bowel dysfunction 58 Non inferiority 58 Hypoactive Sexual Desire Disorder 58 indolent follicular non 57 SNT-MC#/idebenone 57 dose dose escalation 57 clinical trials SGN 57 Diabetic Macular Edema 57 Teva Provides Update 57 telomerase inhibitor drug 57 ER CHOP 57 IMP# 57 Peginterferon alfa 2b 57 metastatic pancreatic 57 Syndax Pharmaceuticals Inc. 57 relapsed MCL 57 prokinetic agent 57 recurrent glioblastoma multiforme 57 Heterozygous Familial Hypercholesterolemia 57 Saforis 57 CIMZIA TM 57 evaluating Prochymal 57 KNS # 57 skateboarding BMX Motocross 57 Triapine R 57 Panzem R NCD 57 IIa clinical 57 EURONEXT SAN 57 Golimumab 57 ENRICH trial 57 azathioprine monotherapy 57 investigational protease inhibitor 57 www.ilgenetics.com 57 hypoxia activated prodrug 57 cardiac myosin activator omecamtiv 57 Idenix anticipates 57 trastuzumab DM1 T DM1 57 included exfoliative dermatitis 57 Pivotal Phase III 57 Cloretazine 57 EVIZON TM squalamine lactate 57 Caltech manages 57 MelaFind R 57 ZACTIMA 57 Ocrelizumab 57 follicular Non Hodgkin 57 optimal fattiness 57 Suppository Hydrocortisone Acetate Rectal 57 Sudhir Agrawal D.Phil 57 Lomitapide 57 Hyperparathyroidism 57 Clinical Antipsychotic Trials 57 Ridaforolimus 57 bavituximab monotherapy trial 57 testing huN# DM1 57 Vidaza ® 57 inhaled AAT 57 data management Clintrial 57 Epigenomics proprietary 57 K ras mutations 57 GAMMAGARD 57 Certolizumab 57 Phase III placebo controlled 57 either acutely decompensated 57 Novel Oral 57 Pertuzumab 57 #/#/# Cytokinetics Incorporated 57 Naive Patients 57 previewed ActiveBatch V#.# 57 bile duct tumor 57 glucokinase activator 57 RhuDex R 57 fostamatinib 57 TTF Therapy 57 Abstract Accepted 57 Acute Liver Failure 57 PEGINTRON TM 57 Athletes quaff 57 confidential informants linking 57 www.adeonapharma.com 57 rasagiline tablets 57 receptor inhibiting monoclonal 57 AERAS-#/Crucell Ad# 57 StemEx R 57 Initiated Phase 57 Bomhard Theater Kentucky 57 SPL# Gel vaginal microbicide 57 EOquin TM 57 Amgen Neulasta R 57 PEG INTRON R 57 corticotropin injection 57 PD LID 57 IMPACT IMmunotherapy 57 Elotuzumab 57 Pemetrexed 57 budesonide MMX Phase III 57 Qnexa TM 57 sunitinib malate 57 forodesine purine nucleoside phosphorylase 57 acute humoral rejection 57 Quicksilver Resources filings 57 basal cell carcinoma squamous 57 #:#-#,# CrossRef Medline [002] 57 TransVax ™ 57 ZFP Therapeutics 57 refractory CLL 57 R roscovitine 57 Phase 2b randomized 57 Onyx Pharmaceuticals Announces 57 anti PlGF 57 Biogen Genentech 57 tiagabine 57 Tocosol Paclitaxel 57 Inhaled nitric oxide 57 proprietary intravenous formulation 57 Arch Intern Med 57 myeloproliferative diseases 57 teriflunomide 57 naïve HCV 57 ® darbepoetin alfa 57 PROTECT AF 57 www.telik.com 57 TRAIL receptor antibody mapatumumab